Translationally controlled tumor protein (TCTP) in the human prostate and prostate cancer cells: Expression, distribution, and calcium binding activity-Reference-Cited by-同舟云学术

Translationally controlled tumor protein (TCTP) in the human prostate and prostate cancer cells: Expression, distribution, and calcium binding activity

Published:2004 Issue:2 Volume:60 Page:130-140
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Arcuri Felice,Papa Stefania,Carducci Antonietta,Romagnoli Roberta,Liberatori Sabrina,Riparbelli Maria Giovanna,Sanchez Jean-Charles,Tosi Piero,del Vecchio Maria Teresa

Publisher

Wiley

Subject

Urology,Oncology

Reference48 articles.

1. Regulation of mRNA utilization in mouse erythroleukemia cells induced to differentiate by exposure to dimethyl sulfoxide.

2. Nucleotide sequence of a major messenger RNA for a 21 kilodalton polypeptide that is under translational control in mouse tumor cells

3. cDNA sequence coding for a translationally controlled human tumor protein

4. Translationally controlled tumor protein: A protein identified in several nontumoral cells including erythrocytes

5. Protein expression profiles in human breast ductal carcinoma and histologically normal tissue

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Omics strategies for unveiling male fertility-related biomarkers in livestock: A review;Gene Reports;2024-06

2. Single nucleotide polymorphisms cumulating to genetic variation for fertility in crossbred (Bos taurus × Bos indicus) bull spermatozoa;Animal Biotechnology;2022-09-22

3. A nematode effector inhibits plant immunity by preventing cytosolic free Ca ²⁺ rise;Plant, Cell & Environment;2022-08-04

4. Translationally controlled tumor protein: the mediator promoting cancer invasion and migration and its potential clinical prospects;Journal of Zhejiang University-SCIENCE B;2022-08

5. Targeting TCTP sensitizes tumor to T cell-mediated therapy by reversing immune-refractory phenotypes;Nature Communications;2022-04-19